AIDS and HIV Therapy
Isotretinoin has little impact on cervical cancer risk
Published in AIDS Weekly, July 22nd, 2002
William R. Robinson and colleagues at Texas Tech University's Harrington Cancer Center in Amarillo evaluated isotretinoin's ability to prevent low-grade, benign cervical lesions from progressing to high-grade or malignant lesions during HIV infection.
Although the researchers did uncover some good news for HIV+ women, they also found that isotretinoin failed to provide them with significant protection from cervical lesion progression.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2002-07-22)
More Articles from AIDS Weekly
- AIDS and HIV Therapy
P-glycoprotein inhibitors can increase antiretroviral CNS delivery - Antiretrovial Therapy
Successful antiretroviral treatment has little effect on overall immune function - AIDS and HIV Pathogenesis
Noncytotoxic antiviral mechanisms contribute to persistent infection resistance - AIDS and HIV Therapy
Interleukin-7 increases risk of naive T-cell infection - Cachexia
Loss of lean body mass in HIV-infected men linked to immunological processes - AIDS Prevention
Greater prevention efforts could be cure for rising cost of HIV treatment - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
